On Apr. 10, 2018, Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its 75-acre campus in West Greenwich, R.I. The new plant, the first of its kind in the U.S., will employ Amgen’s proven next-generation biomanufacturing capabilities and manufacture products for global markets.